These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6130954

  • 1. Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity.
    Sanghera MK, McMillen BA, German DC.
    Eur J Pharmacol; 1982 Dec 17; 86(1):107-10. PubMed ID: 6130954
    [Abstract] [Full Text] [Related]

  • 2. The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity.
    Sanghera MK, German DC.
    J Neural Transm; 1983 Dec 17; 57(4):267-79. PubMed ID: 6140300
    [Abstract] [Full Text] [Related]

  • 3. Buspirone increases locus coeruleus noradrenergic neuronal activity in vitro.
    Trulson ME, Henderson LJ.
    Eur J Pharmacol; 1984 Oct 30; 106(1):195-7. PubMed ID: 6529967
    [Abstract] [Full Text] [Related]

  • 4. 5-HT1A agonists uncouple noradrenergic somatodendritic impulse flow and terminal release.
    Broderick PA, Piercey MF.
    Brain Res Bull; 1991 Nov 30; 27(5):693-6. PubMed ID: 1684526
    [Abstract] [Full Text] [Related]

  • 5. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
    Crespi F.
    J Neurosci Methods; 2009 May 30; 180(1):97-105. PubMed ID: 19427535
    [Abstract] [Full Text] [Related]

  • 6. Effect of buspirone on single unit activity in locus coeruleus and dorsal raphe nucleus in behaving cats.
    Wilkinson LO, Abercrombie ED, Rasmussen K, Jacobs BL.
    Eur J Pharmacol; 1987 Apr 07; 136(1):123-7. PubMed ID: 3595712
    [Abstract] [Full Text] [Related]

  • 7. Anxiolytic activity on locus coeruleus-mediated suppression of muricidal aggression.
    Kozak W, Valzelli L, Garattini S.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):323-6. PubMed ID: 6150860
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.
    VanderMaelen CP, Matheson GK, Wilderman RC, Patterson LA.
    Eur J Pharmacol; 1986 Sep 23; 129(1-2):123-30. PubMed ID: 2876903
    [Abstract] [Full Text] [Related]

  • 9. Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus noradrenergic activity.
    Sanghera MK, Coke JA, Williams HL, McMillen BA.
    Brain Res Bull; 1990 Jan 23; 24(1):17-22. PubMed ID: 2310943
    [Abstract] [Full Text] [Related]

  • 10. Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in-vitro.
    Trulson ME, Arasteh K.
    J Pharm Pharmacol; 1986 May 23; 38(5):380-2. PubMed ID: 2872315
    [Abstract] [Full Text] [Related]

  • 11. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
    Geller I, Hartmann RJ.
    J Clin Psychiatry; 1982 Dec 23; 43(12 Pt 2):25-33. PubMed ID: 6130070
    [Abstract] [Full Text] [Related]

  • 12. The non-benzodiazepine anxiolytic buspirone inhibits stress-induced renin secretion and lowers heart rate.
    Van de Kar LD, Urban JH, Lorens SA, Richardson KD.
    Life Sci; 1985 Mar 25; 36(12):1149-55. PubMed ID: 2858796
    [Abstract] [Full Text] [Related]

  • 13. Buspirone, Parkinson's disease, and the locus ceruleus.
    Ludwig CL, Weinberger DR, Bruno G, Gillespie M, Bakker K, LeWitt PA, Chase TN.
    Clin Neuropharmacol; 1986 Mar 25; 9(4):373-8. PubMed ID: 2873889
    [Abstract] [Full Text] [Related]

  • 14. Effects of a potential antipsychotic, BMY 14802, on firing of central serotonergic and noradrenergic neurons in rats.
    VanderMaelen CP, Braselton JP.
    Eur J Pharmacol; 1990 Apr 25; 179(3):357-66. PubMed ID: 1973108
    [Abstract] [Full Text] [Related]

  • 15. Serotonin1A receptor agonists induce Fos protein expression in the locus coeruleus of the conscious rat.
    Hamamura T, Lee Y, Fujiwara Y, Kuroda S.
    Brain Res; 1997 Jun 06; 759(1):156-9. PubMed ID: 9219875
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats.
    Swiergiel AH, Li Y, Wei ZY, Dunn AJ.
    Neurochem Int; 2008 May 06; 52(6):1220-5. PubMed ID: 18280616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.